Coronavirus India Updates: Active Cases Decline; India Adds Over 11,000 New Cases
A health worker prepares a dose of Covaxin in the Covid-19 vaccination room at the Super Speciality Hospital Hospital in Srinagar, India. (Photographer: Sumit Dayal/Bloomberg)

Coronavirus India Updates: Active Cases Decline; India Adds Over 11,000 New Cases

Latest First
  • Oldest First

The Covid-19 pandemic shows signs of receding in India as active cases decline and deaths per-day remain below the 100-mark.

The country reported 84 casualties in the last 24 hours, taking the toll tally to 1.55 lakh in the world’s second-worst infected country, according to the Health Ministry’s update as of 8 a.m. on Feb. 8, 2021.

India also reported more than 11,800 fresh Covid-19 cases, which was lower than than the 11,900 recoveries reported in the day. This lead to a fall in active infections, a day after the country recorded a slight uptick in active cases. To be sure, active cases have fallen below 1.49 lakh after crossing 10 lakh mid-September.

The nation with 1.3 billion people is only behind the U.S. in the number of confirmed infections.

Key figures:

  • Total number of confirmed coronavirus cases: 1,08,38,194
  • Active cases: 1,48,609
  • Cured/discharged/migrated: 1,05,34,505
  • Deaths: 1,55,080
  • Number of fresh cases in last 24 hours: 11,831
  • One-day recoveries: 11,904
  • One-day deaths: 84

Meanwhile, more than 58 lakh people, mostly healthcare workers, have been vaccinated under India’s inoculation drive that began on Jan. 16. The country is set to receive the most number of Covid-19 vaccine doses in the initial distribution from the World Health Organization’s Covax initiative, at a time India’s supply of shots outstrips demand.

Global Update

The U.S. added 106,570 Covid-19 cases, almost 8,000 fewer than the week’s previous low, suggesting that the declining trend in infections is continuing. A new study warns of “further surges” in the U.S. as the coronavirus variant first found in the U.K. likely becomes the dominant strain.

Vaccine developers said they are working on a new shot to combat the South African strain after early data suggested AstraZeneca Plc’s product has limited efficacy against mild disease caused by the variant. South Africa plans to fast-track the rollout of Johnson & Johnson’s vaccine after it showed more efficacy against the variant that makes up more than 90% of new cases.

Over 106 million people have contracted the Covid-19 virus so far with 2.3 million deaths. More than 128 million vaccination shots have been given worldwide.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.